Among those conducting CCSVI research is Dr. Michael Dake, a professor of cardiothoracic surgery at Stanford University School of Medicine.
Dake followed 30 people with MS who had stents implanted to open their veins. Two months after surgery, they reported feeling 50 percent less fatigued than before surgery, Dake said. They continued to be less fatigued at the one-year mark, even improving slightly from where they were two months after surgery, he said.
People who saw the most benefit were those with the relapsing-remitting form of MS, in which periods of remission, when the person feels relatively good, are followed by MS flares, Dake said.
而且對於反覆發作型的MS病患而言術後的反應更佳。
People with more aggressive or more advanced forms of MS, including primary and secondary progressive MS, reported about a 40 percent drop in fatigue two months after the surgery, but the effect did not last at the one-year mark, Dake said.
Dake was scheduled to present his findings this week at the International Symposium on Endovascular Therapy in Miami Beach。 Dake博士這星期將會把他的結果在邁阿密的國際靜脈醫療會議中呈現和討論
This is up significantly from a year ago. At the beginning of December 2009, the total number of PML cases was "only" 28, with 5 of those people dying.
Part of the increase in PML is attributed to the fact that more people are passing the 2-year mark for infusions. The risk of PML appears to increase from approximately .01 per 1000 in people receiving 12 infusions or less to more than 2.05 per 1000 in people who have received more than 24 infusions.
更多資訊如下:
Here’s what I have: 82 total, with
35 US
40 EU 5 ROW
Here’s the link to the website where I get my info. It seems to be the definitive source for Tysabri/PML info